Value Equity Research
  • Home
  • Company Reports
  • Quarterly Snaphots
  • Capital Discipline Weekly
  • Capital Allocation League
  • About
Sign in Subscribe
By Value Equity Research in Healthcare — 04 Nov 2025

AbbVie Inc. (ABBV): Heavy R&D investment reshapes cash generation and margins

AbbVie Inc. (ABBV): Heavy R&D investment reshapes cash generation and margins

This post is for paying subscribers only

Subscribe now

Already have an account? Sign in

Previous

Live Nation Entertainment, Inc. (LYV): Venue-centric model with pressured cash conversion profile

Next

McDonald's Corporation (MCD): Stable cash generation with elevated investment outflows

You might also like...

Lululemon Athletica Inc. (LULU): Capital Discipline Analysis — Revenue growth amid margin compression and cost expansion
Consumer Cyclical

Lululemon Athletica Inc. (LULU): Capital Discipline Analysis — Revenue growth amid margin compression and cost expansion

Lululemon demonstrates exceptional capital efficiency with best-in-class ROIC and strong free cash
Read More
Spotify Technology S.A. (SPOT): Capital Discipline Analysis — Revenue to Margin Conversion Under Cost Control
Communication Services

Spotify Technology S.A. (SPOT): Capital Discipline Analysis — Revenue to Margin Conversion Under Cost Control

Spotify demonstrates exceptional capital efficiency with perfect ROIC and free cash flow
Read More
Booking Holdings Inc. (BKNG): Revenue to cash conversion with margin compression
Consumer Cyclical

Booking Holdings Inc. (BKNG): Revenue to cash conversion with margin compression

Booking Holdings Inc. (BKNG): FY2025 FY analysis of earnings as of 2025-12-31
Read More
Airbnb, Inc. (ABNB): Growth under elevated investment intensity
Consumer Cyclical

Airbnb, Inc. (ABNB): Growth under elevated investment intensity

Airbnb, Inc. (ABNB): FY2025 FY analysis of earnings as of 2025-12-31 Source:
Read More
Value Equity Research © 2026
  • Sign up
  • Disclaimer
Powered by Ghost